HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leigh Howard Selected Research

ascrinvacumab

10/2019A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leigh Howard Research Topics

Disease

2Neoplasms (Cancer)
05/2015 - 02/2015
1Colorectal Neoplasms (Colorectal Cancer)
10/2019
1Posterior Leukoencephalopathy Syndrome
02/2015
1Uveitis
02/2015
1Wounds and Injuries (Trauma)
02/2015

Drug/Important Bio-Agent (IBA)

1Activin Receptors (Activin Receptor)IBA
10/2019
1ascrinvacumabIBA
10/2019
1Monoclonal AntibodiesIBA
10/2019
1regorafenibIBA
10/2019
1Sildenafil Citrate (Viagra)FDA Link
05/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2015
1Phosphotransferases (Kinase)IBA
05/2015
1Bevacizumab (Avastin)FDA Link
02/2015
1Biomarkers (Surrogate Marker)IBA
02/2015
1PaxillinIBA
02/2015
1intetumumabIBA
02/2015

Therapy/Procedure

1Drug Therapy (Chemotherapy)
05/2015